Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

The commentary suggests that certain hair and skin care products may be linked to frontal fibrosing alopecia, but not sunscreens, and calls for more thorough research on the causes.

Multivitamins can help hair growth and health, especially if you have nutritional deficiencies, but should be used carefully.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Emotional Freedom Techniques (EFT) treatment improved seed germination and growth, suggesting mood affects seed viability.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

Dietetic-led cognitive-behavioral therapy may improve treatment for adults with ARFID.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

Combining a plant-based diet with emotional intelligence can lower BMI and bad cholesterol.

The Theory of Planned Behaviour predicts consumer behavior better when emotions, personality, demographics, and marketing are included.

Cognitive-behavioral therapy with habit reversal training is the most effective treatment for trichotillomania.

Emotional intelligence needs different measurement tools than IQ.

War veterans need psychological support to improve coping and resilience.

rTMS may help treat trichotillomania in some patients.

Cognitions significantly influence Trichotillomania, suggesting cognitive therapies could help.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

The Italian version of a relationship scale was adapted for cancer patients, showing some differences from the original and suggesting its use could improve therapy and treatment adherence.

Behavioral interventions, especially habit reversal training, are most effective for treating trichotillomania in children.

Rosacea patients often discuss treatments and emotional struggles online, highlighting the need for professional support.

Community support and mindset changes helped a woman stop hair-pulling for 9 months.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

Isolation stress in rats reduces brain enzyme levels, affecting dopamine function.

Behavioral therapies are more effective than drugs for treating trichotillomania.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.